论文部分内容阅读
目的:研究舒普深联合左氧氟沙星治疗哮喘并发肺部感染的临床疗效。方法:选取2012年6月到2016年6月来我院治疗的哮喘合并肺部感染患者80例,按照患者入院时间将患者随机分为观察组(n=40)和对照组(n=40)。对照组采用舒普深治疗,观察组采用舒普深和左氧氟沙星联合治疗,两组患者均治疗2周,观察比较两组患者的治疗疗效、病原菌清除率以及肺功能的恢复情况。结果:观察组患者的总效率、病原菌清除率均较对照组总有效率显著提高,差异具有统计学意义(P<0.05)。与治疗前相比,两组患者治疗后的肺功能指标均显著提高,且观察组患者的肺功能指标较治疗组改善更显著。结论:舒普深联合左氧氟沙星治疗哮喘并发肺部感染临床疗效显著,可显著改善患者肺功能。
Objective: To study the clinical effect of Shu Pu Shen combined with levofloxacin in the treatment of asthma complicated with pulmonary infection. Methods: Eighty patients with asthma with pulmonary infection who were treated in our hospital from June 2012 to June 2016 were randomly divided into observation group (n = 40) and control group (n = 40) according to the patient’s admission time. . The control group was treated with Shu Pushen, the observation group was treated with Shu Pu Shen and levofloxacin, the two groups were treated for 2 weeks, the curative effect, clearance rate of pathogenic bacteria and recovery of lung function were observed and compared between the two groups. Results: The total effective rate and the pathogen clearance rate in the observation group were significantly higher than those in the control group, with statistical significance (P <0.05). Compared with the pre-treatment, the two groups of patients after treatment of lung function indicators were significantly improved, and the observation group patients with lung function index improved more significantly than the treatment group. Conclusion: Shu Pu Shen combined with levofloxacin in the treatment of asthma complicated with pulmonary infection clinical significant effect, can significantly improve lung function in patients.